VIR BIOTECHNOLOGY, INC. (VIR)
Clinical trial NCT05461170 updates: 1. completion date: 2029-08-01 → 2032-05-01 2. primary completion date: 2029-08-01 → 2031-11-01
Clinical trial NCT05461170 updates: 1. completion date: 2029-08-01 → 2032-05-01 2. primary completion date: 2029-08-01 → 2031-11-01
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical